BioVaxys Technology Corp. (CSE:BIOV)
Canada flag Canada · Delayed Price · Currency is CAD
0.0400
0.00 (0.00%)
Apr 25, 2025, 3:59 PM EDT

BioVaxys Technology Income Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jan '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2019
Selling, General & Admin
3.532.822.122.344.120.42
Upgrade
Research & Development
0.0300.130.960.730.24
Upgrade
Operating Expenses
3.923.122.43.85.981.01
Upgrade
Operating Income
-3.92-3.12-2.4-3.8-5.98-1.01
Upgrade
Interest & Investment Income
----00
Upgrade
Currency Exchange Gain (Loss)
-0.06-0-0.03-0.02-0.02-0
Upgrade
Other Non Operating Income (Expenses)
-0.21-0.17-4.03-0.26-0.46-0.09
Upgrade
EBT Excluding Unusual Items
-4.19-3.3-6.46-4.08-6.46-1.1
Upgrade
Asset Writedown
-1.29-1.29-1.45-7.4--
Upgrade
Other Unusual Items
-0.070.630.21-0.25--
Upgrade
Pretax Income
-5.54-3.95-7.69-11.73-6.46-1.1
Upgrade
Earnings From Continuing Operations
-5.54-3.95-7.69-11.73-6.46-1.1
Upgrade
Earnings From Discontinued Operations
------0.07
Upgrade
Net Income
-5.54-3.95-7.69-11.73-6.46-1.17
Upgrade
Net Income to Common
-5.54-3.95-7.69-11.73-6.46-1.17
Upgrade
Shares Outstanding (Basic)
225196134988328
Upgrade
Shares Outstanding (Diluted)
225196134988328
Upgrade
Shares Change (YoY)
58.48%45.90%36.63%18.39%193.97%171.65%
Upgrade
EPS (Basic)
-0.02-0.02-0.06-0.12-0.08-0.04
Upgrade
EPS (Diluted)
-0.02-0.02-0.06-0.12-0.08-0.04
Upgrade
EBIT
-3.92-3.12-2.4-3.8-5.98-1.01
Upgrade
Advertising Expenses
-0.42-0.171.720.08
Upgrade
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.